New drug aims to unclog lungs in chronic bronchiectasis patients

NCT ID NCT07547436

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called SAR445399 in 70 adults aged 18-80 with non-cystic fibrosis bronchiectasis, a lung condition causing mucus buildup and infections. Participants receive either the drug or a placebo for 24 weeks to see if it reduces mucus plugs seen on CT scans. The goal is to improve breathing and reduce flare-ups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-CYSTIC FIBROSIS BRONCHIECTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchiectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Advanced Pulmonary Research Institute- Site Number : 8400001

    RECRUITING

    Loxahatchee Groves, Florida, 33470, United States

  • Clinical Research Associates of Central Pennsylvania- Site Number : 8400006

    RECRUITING

    DuBois, Pennsylvania, 15801, United States

  • Hull and Hull Medical Specialists- Site Number : 8400002

    RECRUITING

    Plantation, Florida, 33324, United States

  • Pulmonary Associates - Phoenix - East McDowell Road- Site Number : 8400008

    RECRUITING

    Phoenix, Arizona, 85006, United States